“…After exclusion of studies using overlapping or same outcome data, 29 articles based on non-overlapping populations were eligible for inclusion in one or more meta-analyses. The number of studies included in each outcome category was seven for circulatory system diseases, 4 , 5 , 6 , 7 , 8 , 9 , 10 six for digestive system diseases, 11 , 12 , 13 , 14 , 15 , 16 six for nervous system diseases, 17 , 18 , 19 , 20 , 21 three for musculoskeletal system outcomes, 22 , 23 , 24 two for endocrine and metabolic diseases, 25 , 26 two for eye diseases, 27 , 28 and four for neoplasms. 29 , 30 , 31 , 32 In addition to the included studies, 123 de novo MR analyses ( n =51 for smoking initiation, n = 72 for lifetime smoking) were conducted.…”